Last update 24 Mar 2025

Sonepcizumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
ASONEP, iSONEP, Sonepcizumab/LT1009
+ [3]
Action
inhibitors
Mechanism
Sphingosine 1 phosphate inhibitors
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Unresectable Renal Cell CarcinomaPhase 2
United States
01 Feb 2013
Choroidal NeovascularizationPhase 2
United States
01 Aug 2012
Wet age-related macular degenerationPhase 2
United States
01 Aug 2012
Wet Macular DegenerationPhase 2
United States
01 Aug 2012
Dystrophy, MacularPhase 2--
Renal Cell CarcinomaPhase 2--
Dystonia 18Phase 1
United States
01 Mar 2011
Dystonia 18Phase 1
United States
01 Mar 2011
Polypoidal choroidal vasculopathyPhase 1
United States
01 Mar 2011
Polypoidal choroidal vasculopathyPhase 1
United States
01 Mar 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
158
sham injection+4.0 mg iSONEP
(Monotherapy)
tgvxywjeey(vderjeothe) = wsjzdorgpk gpakiayroj (zdkpxieplo, 1.515)
-
17 Oct 2016
(0.5 mg iSONEP & Lucentis/Avastin/Eylea)
tgvxywjeey(vderjeothe) = czntbqwtrt gpakiayroj (zdkpxieplo, 1.459)
Phase 1
-
pkvdavkwgr(laqvhghodh) = mzqizynezw jxjktlcxrv (mzgfxtiyum )
-
20 May 2010
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free